SCHEMBL3480703

SCHEMBL3480703

CCC1CC(N2CCC(C(=O)O)CC2)CCN1c1nccc(Nc2ccc(N(CC)CC)cc2C)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.38
POLB P06746 2/20 0.38
KMT2A Q03164 1/20 0.37
CCNE1 P24864 6/20 0.36
CDK2 P24941 6/20 0.36
GFER P55789 3/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALOX15 P16050 1/20 0.34
HTT P42858 1/20 0.34
THRB P10828 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34
ROCK2 O75116 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
RPS6KA2 Q15349 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3480701 0.80 CDK2 (0.43) MAPTPOLBKMT2ACCNE1CDK2
SCHEMBL3480694 0.71 PSEN1 (0.42) MAPTPOLBCCNE1CDK2ROCK2
SCHEMBL3480665 0.71 CDK2 (0.41) MAPTPOLBCCNE1CDK2
SCHEMBL3480972 0.71 CDK2 (0.41) MAPTPOLBCCNE1CDK2ROCK2
SCHEMBL8144017 0.70 HSP90AA1 (0.49) ROCK2HSP90AA1HSP90AB1
SCHEMBL8141002 0.68 PSEN1 (0.41) MAPTPOLBCCNE1CDK2GFER
SCHEMBL3017714 0.68 ACHE (0.56) CCNE1CDK2HSP90AA1HSP90AB1
SCHEMBL3480971 0.68 MAP4K1 (0.40) CCNE1CDK2HSP90AA1HSP90AB1
SCHEMBL3029387 0.66 ROCK2 (0.50) CCNE1CDK2ROCK2HSP90AA1HSP90AB1
SCHEMBL3480967 0.66 CCR4 (0.43) CCNE1CDK2TSHRROCK2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252803-B2 Piperidine derivatives MERCK SHARP & DOHME CORP. (US) 2012-08-28 US disclosed
US-20100041680-A1 PIPERIDINE DERIVATIVES MERCK SHARP & DOHME CORP. 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041680-A1 PIPERIDINE DERIVATIVES PSEN1, PSEN2, APBA1 MAPT 11/4885POLB 284/4885KMT2A 2911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.